Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
Status unconfirmed · Phase 2
Conditions studied: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
In brief
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Randomized phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have ovarian, fallopian tube, or peritoneal cancer.
Key facts
- Study ID
- NCT00004064
- Run by
- AltaRex
- People needed
- 102
- Starts
- 1998-11-01
- Last updated by the study team
- 2013-11-06
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Gynecologic Oncology Associates — Newport Beach, California, United States
- Lee Memorial Health System — Fort Myers, Florida, United States
- Walt Disney Memorial Cancer Institute — Orlando, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Mercy Medical Center, Inc. — Baltimore, Maryland, United States
- Barnes-Jewish Hospital — St Louis, Missouri, United States
- St. John's Mercy Medical Center — St Louis, Missouri, United States
- University of Oklahoma College of Medicine — Oklahoma City, Oklahoma, United States
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
- Palmetto Richland Memorial Hospital — Columbia, South Carolina, United States
- Texas Oncology, P.A. — Dallas, Texas, United States
- Cancer Center, University of Virginia HSC — Charlottesville, Virginia, United States
- Riverside Regional Medical Center — Newport News, Virginia, United States
- Ottawa Regional Cancer Center - General Division — Ottawa, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.